Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer

Gut

Volumn 62, Issue 6, 2013, Pages 833-841

  Wang, Shiyan ^a   Cheng, Yingduan ^a   Du, Wan ^a,b   Lu, Leina ^a   Zhou, Liang ^a   Wang, Huating ^a   Kang, Wei ^a   Li, Xiaoxing ^a   Tao, Qian ^a   Sung, Joseph J Y ^a   Yu, Jun ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 545;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMETHYLATION; DOWN REGULATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOLUS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN TARGETING; RNA TRANSCRIPTION; STOMACH CANCER; TRANSCRIPTION REGULATION;

BLOTTING, NORTHERN; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; KAPLAN-MEIER ESTIMATE; NUCLEAR PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, RIBOSOMAL; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS; ZINC FINGERS;

EID: 84876918167     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301776     Document Type: Article

References (24)

1. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003;4:231.
2. Zeng W, Ball AR Jr, Yokomori K. HP1: heterochromatin binding proteins working the genome. Epigenetics 2010;5:287-92.
3. Cheng Y, Geng H, Cheng SH, et al . KRAB zinc finger protein ZNF382 is a proapoptotic tumour suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 2010;70:6516-26.
4. Yu J, Cheng YY, Tao Q, et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2009;136:640-51.
5. Torrano V, Navascués J, Docquier F, et al. Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation- dependent mechanism. J Cell Sci 2006;119:1746-59. (Pubitemid 43811001)
6. Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 2006;1:729-48.
7. Pederson T. The nucleolus. Cold Spring Harb Perspect Biol 2011;3:pii: a000638.
8. Grandori C, Gomez-Roman N, Felton-Edkins ZA, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 2005;7:311-18. (Pubitemid 40331133)
9. Frescas D, Guardavaccaro D, Bassermann F, et al. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 2007;450:309-13. (Pubitemid 350100537)
10. Santoro R. The silence of the ribosomal RNA genes. Cell Mol Life Sci 2005;62:2067-79. (Pubitemid 41291663)
11. Bártová E, Horáková AH, Uhlí rová R, et al. Structure and epigenetics of nucleoli in comparison with non-nucleolar compartments. J Histochem Cytochem 2010;58:391-403.
12. Drygin D, Rice WG, Grummt I. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol 2010;50:131-56.
13. Derenzini M, Montanaro L, Treré D. What the nucleolus says to a tumour pathologist. Histopathology 2009;54:753-6.
14. Montanaro L, Treré D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol 2008;173:301-10.
15. van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010;10:301-9.
16. Azuma M, Toyama R, Laver E, et al. Perturbation of rRNA synthesis in the bap28 mutation leads to apoptosis mediated by p53 in the zebrafish central nervous system. J Biol Chem 2006;281:13309-16. (Pubitemid 43855241)
17. Yuan X, Zhou Y, Casanova E, et al. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell 2005;19:77-87. (Pubitemid 40884659)
18. Huang M, Ji Y, Itahana K, et al. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. Leuk Res 2008;32:131-41. (Pubitemid 350103806)
19. Kalita K, Makonchuk D, Gomes C, et al. Inhibition of nucleolar transcription as a trigger for neuronal apoptosis. J Neurochem 2008;105:2286-99. (Pubitemid 351782259)
20. Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010;29:4253-60.
21. Best JD, Carey N. Epigenetic opportunities and challenges in cancer. Drug Discov Today 2010;15:65-70.
22. Bannister AJ, Zegerman P, Partridge JF, et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001;410:120-4. (Pubitemid 32225848)
23. Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 2004;5:296-304. (Pubitemid 38480610)
24. Groner AC, Meylan S, Ciuffi A, et al. KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet 2010;6:e1000869.